Balloon Valvuloplasty Device Market Expected to Achieve 5.6% CAGR by 2029: Growth Forecast Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Balloon Valvuloplasty Device Market Size By 2025?
Strong growth has been observed in the balloon valvuloplasty device market size in the past few years. A rise from $2.44 billion in 2024 to $2.57 billion in 2025 is predicted, showcasing a compound annual growth rate (CAGR) of 5.3%. Factors contributing to this growth during the historic period include increased spending in healthcare sector, development of healthcare facilities, enhanced awareness and diagnostic skills, preference towards outpatient departments, expansion of telemedicine for better access, and focus on enhancing patients' quality of life.

How Big Is the Balloon Valvuloplasty Device Market Size Expected to Grow by 2029?
The market size for balloon valvuloplasty devices is anticipated to experience robust expansion in the forthcoming years, ascending to $3.2 billion in 2029 with a compound annual growth rate (CAGR) of 5.6%. The escalation anticipated in the forecast period can be credited to the growing incidence of heart valve illnesses in the aging population worldwide, rising preference for less intrusive heart valve treatments, swift approvals and clearances of new balloon valvuloplasty devices, and a shift towards cost-effective healthcare. Key trends predicted within the same period are improved imaging techniques assisting in accurate diagnosis, customized patient treatment approaches, heightening investment in research and development activities, development of regenerative methods in handling cardiovascular diseases, and the adoption of digital health technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/balloon-valvuloplasty-device-global-market-report

Which Key Market Drivers Powering Balloon Valvuloplasty Device Market Expansion and Growth?
The balloon valvuloplasty device market is expected to grow, powered by an increasing preference for minimally invasive procedures. These medical techniques involve small cuts or natural body openings, lessening trauma and facilitating swifter recovery than conventional surgical procedures. A growing demand for these minimally invasive procedures is evident due to their shorter recovery periods, decreased risk of complications, and reduced post-surgical discomfort in comparison with traditional surgeries. Balloon valvuloplasty devices, employed in minimally invasive surgeries to enlarge constricted heart valves, enhance blood flow, and alleviate symptoms, are gaining popularity. For example, in January 2024, Intuitive Surgical Inc., a producer of robotic products from the US, announced the placement of 415 da Vinci surgical systems (robotic surgical systems employing a minimally invasive surgical technique) in the fourth quarter of 2023, amounting to a 12% increase over 2022. Hence, this growing preference for minimally invasive procedures bolsters the growth of the balloon valvuloplasty device market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17090&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Balloon Valvuloplasty Device Market?
To gain a competitive advantage in the balloon valvuloplasty device market, major firms are concentrating on producing innovative products, one being Pacing Guidewires. This specialized wire, critical to ensure a stable cardiac rhythm during the procedure, facilitates the secure insertion and inflation of the balloon catheter to dilate a constricted valve. For instance, Teleflex Incorporated, an American medical device enterprise, obtained approval from the Food and Drug Administration (FDA) for their new device, the Wattson Temporary Pacing Guidewire, in June 2023. The device, tailored specifically for use during transcatheter aortic valve replacement (TAVR) and balloon aortic valvuloplasty (BAV) procedures, boasts dual functionality. It not only aids valve delivery but also supports ventricular bipolar pacing during these intricate heart procedures. With its flexible distal pigtail shape, several electrodes, and bipolar design, the device is engineered to lessen the risk of ventricular perforation and ensure dependable electrical capture during rapid pacing.

What Are the Emerging Segments in the Balloon Valvuloplasty Device Market?
The balloon valvuloplasty device market covered in this report is segmented -

1) By Product Type: Standard Balloon, Cutting Balloon, Scoring Balloon, High-Pressure Balloon, Low-Pressure Balloon
2) By Age Group: Pediatric, Adult
3) By End-use: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End Uses

Subsegments:
1) By Standard Balloon: Non-Compliant Balloons, Compliant Balloons
2) By Cutting Balloon: Single-Cutting Balloon, Multi-Cutting Balloon
3) By Scoring Balloon: Single-Score Balloons, Dual-Score Balloons
4) By High-Pressure Balloon: Non-Compliant High-Pressure Balloons, Compliant High-Pressure Balloons
5) By Low-Pressure Balloon: Semi-Compliant Low-Pressure Balloons, Non-Compliant Low-Pressure Balloons

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=17090&type=smp

Who Are the Global Leaders in the Balloon Valvuloplasty Device Market?
Major companies operating in the balloon valvuloplasty device market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Philips Healthcare, Becton Dickinson Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Teleflex Incorporated, Biotronik SE & Co. KG, Integer Holdings Corporation, LivaNova PLC, Cordis Corporation, NuMED Inc., Pfm Medical GmbH, Tokai Medical Products Inc, Translumina GmbH, Meril Life Sciences Pvt. Ltd., Toray Medical Company Limited, QT Vascular Ltd.

Which are the Top Profitable Regional Markets for the Balloon Valvuloplasty Device Industry?
North America was the largest region in the balloon valvuloplasty device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the balloon valvuloplasty device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17090

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.